PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
22.84%
Net income growth above 20% – Outstanding. Warren Buffett would verify whether this rise is driven by core operations or one-time items.
7.12%
D&A 5-10% yoy – Noticeable rise. Peter Lynch would hope new assets produce higher revenue to offset the expense.
No Data
No Data available this quarter, please select a different quarter.
-26.57%
Negative yoy SBC growth reduces new equity issuance. Benjamin Graham would verify that enough talent investment remains for growth.
-21.66%
A negative yoy change in working capital can free up cash. Benjamin Graham would confirm it is not from falling demand or asset disposal.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
A negative yoy AP change means the firm is paying down supplier credit. Benjamin Graham would see it as lowering short-term liabilities if revenue is stable.
161.21%
Above 30% yoy – Major jump. Philip Fisher would demand details on these miscellaneous lines to ensure transparency.
200.00%
Above 30% yoy – Major jump. Philip Fisher would investigate whether this is a recurring or truly one-time distortion.
22.87%
Operating cash flow growth above 20% – Exceptional. Warren Buffett would ensure it stems from sustainable operations, not just working capital shifts.
-183.51%
A negative yoy CapEx shift boosts near-term FCF if capacity is adequate. Benjamin Graham would see it as beneficial unless future growth is sacrificed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-183.51%
A negative yoy shift suggests smaller outflows or net inflows if disposals exceed invests. Benjamin Graham would see a short-term FCF benefit unless growth is compromised.
No Data
No Data available this quarter, please select a different quarter.
-107.12%
A negative yoy figure could mean fewer or no new shares or even net buybacks. Benjamin Graham would see it as positive unless expansions need capital that internal cash cannot provide.
No Data
No Data available this quarter, please select a different quarter.